Cd109 - CD109 antigen Gene

Also Known as GARP; 9930012E15Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 235505

Summary

Predicted to enable transforming growth factor beta binding activity. Acts upstream of or within several processes, including negative regulation of keratinocyte proliferation; osteoclast fusion; and regulation of keratinocyte differentiation. Located in extracellular space. Is expressed in brain. Orthologous to human CD109 (CD109 molecule). [provided by Alliance of Genome Resources, Apr 2022]

Cd109 Products (1)

mRNA Protein Name
NM_153098.3 NP_694738.1 CD109 antigen precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence Références Source
acts upstream of or within hair follicle development IMP
IMP: Inferred from mutant phenotype
22846721 MGI
acts upstream of keratinocyte proliferation IMP
IMP: Inferred from mutant phenotype
22846721 MGI
acts upstream of or within negative regulation of keratinocyte proliferation IMP
IMP: Inferred from mutant phenotype
22846721 MGI
acts upstream of or within negative regulation of protein phosphorylation IMP
IMP: Inferred from mutant phenotype
22490868 MGI
acts upstream of or within negative regulation of stem cell proliferation IMP
IMP: Inferred from mutant phenotype
22846721 MGI
acts upstream of or within osteoclast fusion IMP
IMP: Inferred from mutant phenotype
23593435 MGI
acts upstream of protein phosphorylation IMP
IMP: Inferred from mutant phenotype
22490868 MGI
acts upstream of or within regulation of keratinocyte differentiation IMP
IMP: Inferred from mutant phenotype
22490868 MGI
acts upstream of stem cell proliferation IMP
IMP: Inferred from mutant phenotype
22846721 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

CD109 antigen

  • GPI-anchored alpha 2 macroglobulin-related protein

  • Gov platelet alloantigens

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Nom du produit
Effect
Pureté
Rare Diseases
HY-RS02188 CD109 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19660 Cd109 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26153 Cd109 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Cd109 NCBI NCBI:135228